Bristol Myers Squibb announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended the approval of Opdivo in combination with cisplatin...

Related Keywords

Dana Walker , Bristol Myers Squibb , European Union , Global Program Leader , European Medicines Agency , Committee For Medicinal Products Human Use , European Commission , Medicinal Products , Human Use , Vice President , Genitourinary Cancers , Bristol Myers ,